Literature DB >> 31541270

Four-year course of quality of life and obsessive-compulsive disorder.

Karin C P Remmerswaal1, Neeltje M Batelaan2, Adriaan W Hoogendoorn2, Nic J A van der Wee3, Patricia van Oppen2, Anton J L M van Balkom2.   

Abstract

OBJECTIVE: Patients with obsessive compulsive disorder (OCD) have high disease burden. It is important to restore quality of life (QoL) in treatment, so that patients become able to live a fulfilling life. Little is known about the longitudinal course of QoL in patients with OCD, its association with remission from OCD, and about factors that contribute to an unfavourable course of QoL in remitting patients.
METHODS: Study on the 4-year course of QoL of patients with chronic (n = 144), intermittent (n = 22), and remitting OCD (n = 73) using longitudinal data of the Netherlands Obsessive Compulsive Disorder Association (NOCDA; complete data: n = 239; imputed data n = 382). The EuroQol five-dimensional questionnaire (EQ-5D) utility score was used to assess QoL. In patients with remitting OCD, we examined patient characteristics that contributed to an unfavourable course of QoL, including sociodemographics, OCD characteristics, psychiatric comorbidity, and personality traits.
RESULTS: Course of QoL was associated with course of OCD. QoL improved in those who remitted from OCD; however, even in these patients, QoL remained significantly below the population norms. The correlation between QoL and severity of OCD was only moderate: r = - 0.40 indicating that other factors besides OCD severity contribute to QoL. In remitters, more severe anxiety and depression symptoms were related to a lower QoL. Results were similar in complete and imputed data sets.
CONCLUSIONS: Remission from OCD is associated with improvement of QoL, but comorbid anxiety and depression symptoms hamper the improvement of QoL. QoL could be improved by reducing OCD symptoms in patients with OCD and by treating comorbid anxiety and depression symptoms in remitting patients.

Entities:  

Keywords:  Longitudinal; OCD; Obsessive–compulsive disorder; QoL; Quality of life

Year:  2019        PMID: 31541270     DOI: 10.1007/s00127-019-01779-7

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  8 in total

1.  Effect of sertraline and fluvoxamine on quality of life in patients with obsessive-compulsive disorder: A 12-week interventional study.

Authors:  Jasmine Brar; Ajeet Sidana; Nidhi Chauhan; Manoj Kumar Bajaj
Journal:  Ind Psychiatry J       Date:  2022-03-04

2.  A Cross-Sectional Study on Cognitive Errors and Obsessive-Compulsive Disorders among Young People During the Outbreak of Coronavirus Disease 2019.

Authors:  Elham Darvishi; Solmaz Golestan; Farangis Demehri; Sheida Jamalnia
Journal:  Act Nerv Super (2007)       Date:  2020-10-31

3.  Deep Brain Stimulation for Obsessive-Compulsive Disorder: Real World Experience Post-FDA-Humanitarian Use Device Approval.

Authors:  Lora Kahn; Brianne Sutton; Helena R Winston; Aviva Abosch; John A Thompson; Rachel A Davis
Journal:  Front Psychiatry       Date:  2021-03-24       Impact factor: 4.157

4.  Predictors of Intensive Treatment in Patients With Obsessive-Compulsive Disorder.

Authors:  Johanna A M du Mortier; Karin C P Remmerswaal; Neeltje M Batelaan; Henny A D Visser; Jos W R Twisk; Patricia van Oppen; Anton J L M van Balkom
Journal:  Front Psychiatry       Date:  2021-04-12       Impact factor: 4.157

Review 5.  Anxiety, Depression and Quality of Life-A Systematic Review of Evidence from Longitudinal Observational Studies.

Authors:  Johanna Katharina Hohls; Hans-Helmut König; Eleanor Quirke; André Hajek
Journal:  Int J Environ Res Public Health       Date:  2021-11-16       Impact factor: 3.390

6.  Dopamine Transporter Knockout Rats Show Impaired Wellbeing in a Multimodal Severity Assessment Approach.

Authors:  Anne Stephanie Mallien; Laura Becker; Natascha Pfeiffer; Federica Terraneo; Melissa Hahn; Anthonieke Middelman; Rupert Palme; Kerstin Camile Creutzberg; Veronica Begni; Marco Andrea Riva; Damiana Leo; Heidrun Potschka; Fabio Fumagalli; Judith R Homberg; Peter Gass
Journal:  Front Behav Neurosci       Date:  2022-07-11       Impact factor: 3.617

7.  Ventral Capsule/Ventral Striatum Stimulation in Obsessive-Compulsive Disorder: Toward a Unified Connectomic Target for Deep Brain Stimulation?

Authors:  Tim A M Bouwens van der Vlis; Linda Ackermans; Anne E P Mulders; Casper A Vrij; Koen Schruers; Yasin Temel; Annelien Duits; Albert F G Leentjens
Journal:  Neuromodulation       Date:  2020-12-25

8.  The cost of obsessive-compulsive disorder (OCD) in China: a multi-center cross-sectional survey based on hospitals.

Authors:  Weili Yang; Zhen Tang; Xijin Wang; Xiancang Ma; Yuqi Cheng; Bin Wang; Ping Sun; Wenxin Tang; Jia Luo; Changhong Wang; Ping Li; Guiyun Xu; Jun Yan; Vlasios Brakoulias; Zhen Wang
Journal:  Gen Psychiatr       Date:  2021-12-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.